The average vision gains from baseline were comparable between the two treatments in both studies, according to Roche, equivalent to around 17 letters on a standard eye chart. Roche's drug was ...
Therefore, practitioners have had to prescribe many of these ophthalmic preparations empirically. In 1997, the U.S. Congress enacted a new law providing marketing incentives for pediatric drug ...
chloramphenicol ophthalmic ointment and solution, erythromycin ophthalmic ointment, Quixin® ophthalmic solution (levofloxacin), Chibroxin® ophthalmic solution (norfloxacin) and Ilotycin ...
Regeneron is going after Sandoz in a New Jersey federal court over Sandoz’s recently-approved drug Enzeevu, a biosimilar to Regeneron’s blockbuster eye tr ...
Ocugen, Inc. OCGN announced that Health Canada has provided it a No Objection Letter to initiate the phase III liMeliGhT study evaluating its modifier gene therapy product candidate, OCU400, for ...
NHS patients battling Alzheimer's will miss out on a 'miracle' drug proven to tackle the devastating and deadly disease, health chiefs today announced. Lecanemab was hailed as 'the beginning of ...
A decades-old drug used to lower cholesterol levels in the ... carried out in patients enrolled into Scotland’s Diabetic Eye Screening (DES) programme found that, over four years, treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback